“Ki-67 Index and Somatostatin Receptor Expression as Prognostic Markers in Patients with Pancreatic Neuroendocrine Tumours: A Review”, AGDD, vol. 8, no. 1, pp. 5–9, Jul. 2025, doi: 10.5281/zenodo.22202865.